Key result
Thin-cap fibroatheroma is linked to ~3 percentage points higher circulating Mon2 subsets.
Observational (n=79)
Answers are grounded in this paper and cite their sources.
BACKGROUND: While specific patterns of circulating dendritic cells (DCs) and monocytes are associated with the incidence of coronary artery disease, the characterization of circulating DC and monocyte subsets in patients with different stages of atherosclerosis remains unclear. METHODS: Forty-eight patients with unstable angina pectoris (UAP) diagnosed by angiography were enrolled. Likewise, 31 patients with ST-segment elevation myocardial infarction (STEMI) were enrolled and confirmed with the presence of thrombosis by angiography. Plaque features of 48 UAP patients were evaluated at the culprit lesions by OCT. Circulating myeloid DCs (mDCs), plasmacytoid DCs (pDCs) and monocyte subsets were analyzed using flow cytometry. RESULTS: ± 0.06 × 104/ml, p = 0.027). On the other hand, patients with UAP and STEMI had significantly higher proportions and counts of Mon2 subsets. In the OCT subgroup, patients with thin-cap fibroatheroma (TCFA) had higher proportions and absolute number of Mon2 (11.96% ± 4.27% vs. 9.42% ± 4.05%, p = 0.034; 5.17 × 104/ml ± 1.92 × 104/ml vs. 3.53 × 104/ml ± 2.65 × 104/ml, p = 0.045) than those without TCFA. However, there was no remarkable difference in mDC2s between patients with and without TCFA. CONCLUSIONS: Circulating Mon2 appears to be a promising marker for the severity of atherosclerotic plaque.
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2017) conducted an observational in Atherosclerosis (Unstable Angina Pectoris and STEMI) (n=79). Thin-cap fibroatheroma (TCFA) vs. Without thin-cap fibroatheroma (non-TCFA) was evaluated on Proportion of Mon2 subsets (p=0.034). Patients with thin-cap fibroatheroma had higher proportions of circulating Mon2 subsets compared to those without thin-cap fibroatheroma.
Synapse has enriched 10 related papers. Consider them for comparative context: